SARC041: Abemaciclib for Dedifferentiated Liposarcoma
The SARC041 trial found promising results for abemaciclib as a new treatment option for advanced dedifferentiated liposarcoma.
The SARC041 trial found promising results for abemaciclib as a new treatment option for advanced dedifferentiated liposarcoma.